• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

State Report: New Jersey


Commonwealth Fund State Performance Ranking (2007): 26

New Jersey needs an early warning system so it can identify acute-care hospitals in financial distress and intervene to ensure access to care, according to a January report released by Governor Jon S. Corzine's Commission on Rationalizing Healthcare Resources.

The report identified major causes of the industry's overall poor financial health:


In September, a task force made 20 recommendations for improving the efficiency and cost-effectiveness of state health programs. The recommendations focus on the structure of insurance plans and on lowering the cost to the state of prescription drugs and long-term care.

Governor Corzine also signed legislation requiring general hospitals to implement infection prevention programs in their intensive care units. The legislation likewise requires hospitals to report cases of MRSA to the New Jersey Department of Health and Senior Services.


While New Jersey's six commercial HMOs have remained largely consistent in 12 clinical performance categories, customer satisfaction measures were mixed, according to the annual HMO report card. None of the other clinical measures changed by more than 2%, but there was marked change in several customer satisfaction categories

MHE Sources: CMS, Urban Institute, Kaiser Commission on Medicaid and the Uninsured, U.S. Census Bureau, The Commonwealth Fund.

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Related Content
© 2024 MJH Life Sciences

All rights reserved.